top of page
it's where dermatology lives
By John Evans
Nov 15, 20192 min read
More effective rituximab dosing for pemphigus identified
“This is the first study to provide evidence for physicians to justify a lymphoma-dose regimen of rituximab when treating their patients wit
By John Evans, Associate Editor
Nov 4, 20164 min read
Biologics next step for treatment of bullous skin disease?
May be an option in patients who do not respond to other regimens, according to presentation at University at Buffalo While there is a...
Featured Posts
bottom of page